September 12, 2011 | David Jacobs Named Vice President of Engineering and Operations
September 12, 2011 – Newton, Massachusetts. David Jacobs joined Scion Medical Technologies™ (Scion) as Vice President of Engineering and Operations. Mr. Jacobs will oversee global engineering and manufacturing operations for the company, including the Company’s manufacturing facility in Taizhou, China.
“We are thrilled that Dave is joining our team,” said Scion CEO Joseph Siletto. “Dave has a wealth of experience in the medical device industry and brings an invaluable skill set to our company as we look to acquire, license and manufacture medical device products.”
Prior to joining Scion, David was Vice President of Operations at Interlace Medical (Interlace), a venture capital financed medical device start-up that was acquired by Hologic for $125 million in January 2011. Interlace manufactured MyoSure, a minimally-invasive women’s treatment option for the removal of fibroids and polyps.
Prior to Interlace, David was the VP of Engineering and Operations at Intact Medical, a venture capital financed start-up that develops and markets an RF powered breast biopsy device. Before Intact, he was Director of Operations for ACT Medical, a contract engineering and manufacturing company serving the needs of the Medical Device industry. Previously, David managed Research and Development, Engineering, Quality, and Operations at companies including MDI (acquired by Becton Dickinson), NetSilicon (acquired by Digi International), and MPM. David has also served in executive positions in larger companies, such as Barry Wright and Eaton Corporation, a Fortune 100 company.
David has been an adjunct professor of Operations Management at Bentley University, teaching both graduate and undergraduate students, and served as a board member of Scott-Davies an ISO registrar.
About Scion Medical Technologies
Scion Medical Technologies (Scion) is a global medical device company with US headquarters in Massachusetts. Scion has manufacturing, distribution and regulatory expertise in the US and China, and is actively looking to grow its product portfolio by acquiring and licensing medical devices that have received 510(k) clearance or premarket approval from the FDA, or are CE-Marked.